Wellbutrin XL Generic From IntelGenx/Cary Pharma Delayed By Manufacturing, Food Effect Concerns
This article was originally published in The Pink Sheet Daily
Executive Summary
"Complete response" letter from FDA should be addressed by the end of the year, firms state.